Quick Answer
COLLEGIUM PHARMACEUTICAL, INC reported Revenue From Contract With Customer Excluding Assessed Tax of $780.57 million for the year ending 2025.
- COLLEGIUM PHARMACEUTICAL, INC showed an increase of +23.6% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from COLLEGIUM PHARMACEUTICAL, INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), COLLEGIUM PHARMACEUTICAL, INC's Revenue From Contract With Customer Excluding Assessed Tax has grown by 45,520.5%.
- Historical annual values: Fiscal year 2025: $780.57 million | Fiscal year 2024: $631.45 million | Fiscal year 2023: $566.77 million | Fiscal year 2022: $463.93 million | Fiscal year 2021: $276.87 million | Fiscal year 2020: $310.02 million | Fiscal year 2019: $296.70 million | Fiscal year 2018: $280.41 million | Fiscal year 2017: $28.48 million | Fiscal year 2016: $1.71 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: